Updated Jul 17, 2026
Townsend John has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
John Townsend is the Chief Financial Officer of Unicycive Therapeutics, Inc., a biotechnology company focused on developing treatments for kidney diseases. He has been involved in the company's financial operations and strategic planning.
| Role | CFO |
|---|---|
| Notability | 30/100 |
John Townsend is the Chief Financial Officer of Unicycive Therapeutics, Inc., a biotechnology company focused on developing treatments for kidney diseases. He has been involved in the company's financial operations and strategic planning.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Townsend John profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.